Furthermore, molecular analysis using the following markers (BRAF V600E, NRAS, HRAS, KRAS, RET/PTC, and PAX8/PPARg) to evaluate preoperative genetic mutations and rearrangements has been shown to have significant diagnostic value in thyroid nodules with indeterminate cytology (32). The gene discussed is HRAS; the disease is thyroid nodule.